<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7E9FA6C1-AE4C-428E-AD55-646632799B3D"><gtr:id>7E9FA6C1-AE4C-428E-AD55-646632799B3D</gtr:id><gtr:name>University Hospitals of Dusseldorf</gtr:name><gtr:address><gtr:line1>Moorenstrasse 5</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F34AC300-EA0B-49AC-9DE8-DF4287E54B4F"><gtr:id>F34AC300-EA0B-49AC-9DE8-DF4287E54B4F</gtr:id><gtr:name>The Garvan Institute for Medical Research</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:department>Biology and Biochemistry</gtr:department><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7E9FA6C1-AE4C-428E-AD55-646632799B3D"><gtr:id>7E9FA6C1-AE4C-428E-AD55-646632799B3D</gtr:id><gtr:name>University Hospitals of Dusseldorf</gtr:name><gtr:address><gtr:line1>Moorenstrasse 5</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F34AC300-EA0B-49AC-9DE8-DF4287E54B4F"><gtr:id>F34AC300-EA0B-49AC-9DE8-DF4287E54B4F</gtr:id><gtr:name>The Garvan Institute for Medical Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4A52C5ED-044B-4554-8B77-96B319C11EC9"><gtr:id>4A52C5ED-044B-4554-8B77-96B319C11EC9</gtr:id><gtr:firstName>Geoffrey</gtr:firstName><gtr:otherNames>D</gtr:otherNames><gtr:surname>Holman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/12BC0DFF-3890-48F4-88BC-0C05C30BB70E"><gtr:id>12BC0DFF-3890-48F4-88BC-0C05C30BB70E</gtr:id><gtr:firstName>Francoise</gtr:firstName><gtr:surname>Koumanov</gtr:surname><gtr:orcidId>0000-0002-9029-3390</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ003417%2F1"><gtr:id>E7157146-7AB4-4A1C-9C3A-8C35FA85D41E</gtr:id><gtr:title>Elucidation of the final stages in coupling of insulin signalling to GLUT4 translocation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J003417/1</gtr:grantReference><gtr:abstractText>Maintenance of blood glucose levels is critically dependent on insulin stimulated glucose transport in adipose tissue, heart and skeletal muscle. Insulin combines with its receptor on target tissues and this initiates a cascade of linked reactions that ultimately result in the fusion of vesicles containing the glucose transporter protein GLUT4 with the plasma membrane. This latter process increases the availability of transporter molecules and thereby increases glucose transport into the cell. Although many of the links in the cascade are well studied, many technical difficulties have prevented detailed study of the final steps in the sequence, namely the fusion process. The proposed project will utilise novel approaches to study the fusion reaction and the extent to which small G-proteins of the Rab family link with the fusion machinery. We have identified many similarities between the membrane fusion reactions that occur in the pancreatic beta cell (which lead to secretion of insulin) and in insulin target tissues (which are involved in GLUT4 vesicle fusion). These similarities will guide the research objectives and experimental plans. These plans will be directed at advancing knowledge of how specific and known components of the fusion mechanism are linked together by effector proteins that are downstream of Rab proteins. This work is important as the fundamental mechanism that links signalling to regulated membrane fusion underlies many processes in biology and is relevant to human health. Elucidation of common mechanisms for pancreatic insulin-vesicle traffic and insulin target cell GLUT4-vesicle traffic will allow a unification of our understanding of those key reactions that are critical for control of blood glucose. These may become dysfunctional by a common route in metabolic disease including obesity and type 2 diabetes.</gtr:abstractText><gtr:technicalSummary>We plan to study mechanisms involved in regulating the fusion of GLUT4 vesicles with the plasma membrane of insulin target cells. We have identified Rab3 as a target of insulin signalling and using a novel photolabelling procedure have found that the loading of this G-protein is increased by insulin action. This labelling approach has also led to the identification of Rap1 as another regulated G-protein target of insulin action. In the beta cell of the pancreas Rap1 is downstream of trimeric G-proteins that augment glucose-dependent insulin release. Furthermore, it is associated with Rab3 control of vesicle traffic. In addition Munc18 is known to be a critical component of the vesicle fusion in both systems. These similarities have led us to propose that there is a unifying mechanism underlying the membrane fusion roles of these components. We plan to examine whether known Rab3 effectors that link with Munc18 in the pancreas have similar counterparts involved in insulin regulation of GLUT4 vesicle fusion. Therefore, we plan to identify Rab3 effectors in insulin-target tissues and validate their involvement in the fusion reaction. We will then study the interaction of Rab3 and the Rab effectors with Munc18. We will also examine the extent to which Munc18 availability for fusion and interaction with SNARE proteins is dependent of its tyrosine phosphorylation. We will determine whether insulin receptor tyrosine kinase is responsible for this phosphorylation using intact receptor and intact plasma membrane as components in our cell-free fusion system. In addition, we will examine the extent to which Rab3 and its effectors are regulated downstream of trimeric G-proteins and through the intermediate Rap1, as occurs in pancreatic beta cells.</gtr:technicalSummary><gtr:potentialImpactText>Economic impact
Potential Beneficiaries: Pharmaceutical companies (improved products and sales); NHS (improved therapies and interventions); 
 The Holman group has collaborated extensively with UK based Pharmaceutical companies including Glaxo-SmithKline and currently AstraZeneca that have helped translate our research into practice. One example outcome of these studies has been the testing of the potency of an insulin sensitizer that was developed into a highly successful anti-diabetes drug called Rosiglitazone. Information obtained in this collaboration was used to mechanistically validate the drug. Annual sales of this drug peaked at approx $2.5bn in 2006, but declined after reports of adverse effects. Our current work is partially supported AstraZeneca has been supported by two consecutive CASE studentships from 2006-2009 and currently 2009-2013. Both studentships have involved setting up high-throughput cell models for testing drug targets, including insulin sensitive Rab-GAPs. With these continuing links we will be able to translate new output on the proposed project into drug screening programs with an expected eventual impact on new drug sales. Diabetes treatment has economic consequences to the NHS (below).

Social and human health impact 
Potential beneficiaries: General public; NHS; Charities; Policy Makers
 Type 2 diabetes is a major global problem with more than 250 million people worldwide currently living with this condition and by 2025, this total is expected to increase to over 380 million people. Each year another 7 million people develop diabetes. 2.8m people in the UK are now diagnosed with diabetes and it is estimated that 1 million more people may have pre-diabetes. Diabetes can lead to complications including kidney failure, coronary heart disease, stroke, blindness and foot amputation. It is estimated that Diabetes treatment (mainly type 2) accounts for an estimated 5% of all NHS expenditure. A detailed understanding of the underlying biological system is key for developing effective diagnostic tools, causal intervention strategies and in supporting public health advice (through government departments and charities). Providing a full pathway from insulin receptor to glucose transporter will impact on strategies for the control of glycemia, energy homeostasis and bodyweight. Therefore there is potential to change behaviours with associated improvements in health outcomes. 
 The targeting of this fundamental research area will reduce animal use by generating more targeted drug discovery. In addition it will provide a focused and directed range of parameters to be monitored in human subjects undergoing clinical drug trials.

Skills and training impact
Potential beneficiaries: Next generation research students; Pharmaceutical companies; Health coaching 
 The proposed research on insulin action will involve postgraduate students who will benefit from training in the novel methods and approaches used by our group. We use a combination of cell physiology and biochemistry approaches. We also have chemical biology input with generation of new tools and reagents for analysis of aspects of insulin action. This wide range of skills will be passed on in training of new PhD students. We hope to continue to recruit students who can interact with pharmaceutical companies. Students trained in this way will be able to pass on skills to a range of employment sectors but specifically sectors concerned with treatments for obesity and type 2 diabetes. There are currently two PhD students in the Holman group. One of these is a CASE student with AstraZeneca. Holman has successfully trained 27 previous PhD students. Our interaction with Sports and Exercise Science PhD and MSc students allows us to share expertise in metabolism and signalling with those contemplating careers in human health related areas such as exercise and diet coaching.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>394471</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital D?sseldorf</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Diabetes Center</gtr:department><gtr:description>Diabetes Institute, Dusseldorf</gtr:description><gtr:id>DF261912-3E72-4216-8B18-E072D363F9A1</gtr:id><gtr:impact>Unpublished data
Sabbatical visit to the German Diabetes Centre in 2013 sponsored by DAAD</gtr:impact><gtr:outcomeId>VLCaiepTCwU-1</gtr:outcomeId><gtr:partnerContribution>Collaboratively we are studying the GTPase labelling in knockout animals with deletions in TBC1D1 and TBC1D4 that have been generated by the Dr Hadi Al Hasani at the German Diabetes Center</gtr:partnerContribution><gtr:piContribution>Generation of a new reagent for labelling the substrates of TBC1D1 and TBC1D4. These proteins are Rab GAPs</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Health Bath</gtr:department><gtr:description>Breakfast project</gtr:description><gtr:id>8125F411-5D1C-4A1E-B739-F3CE097903BF</gtr:id><gtr:impact>Publication in Trials</gtr:impact><gtr:outcomeId>D8ajnADAkAw-1</gtr:outcomeId><gtr:partnerContribution>Application of insulin sensitivity assays to human subjects under varying fasting regimes</gtr:partnerContribution><gtr:piContribution>Setting up assays for determining insulin sensitivity in adipose tissue</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CASE1</gtr:description><gtr:id>C641C219-EE2B-4DC7-81C1-A64DBAC68CF5</gtr:id><gtr:impact>Publication ID 19915010</gtr:impact><gtr:outcomeId>F3F9EB24245-1</gtr:outcomeId><gtr:partnerContribution>shared expertise</gtr:partnerContribution><gtr:piContribution>Setting up of assays for measuring GLUT4 translocation in a muscle cell line</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Garvan Institute for Medical Research</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Proteomics of insulin action on GLUT4</gtr:description><gtr:id>2B59E275-FE8A-4BDA-B57E-EB8B322D7789</gtr:id><gtr:impact>New data</gtr:impact><gtr:outcomeId>AUedSyTZNKA-1</gtr:outcomeId><gtr:partnerContribution>Proteomic analysis</gtr:partnerContribution><gtr:piContribution>Supply of material for analysis</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A GTP analogue that can detect the activation of GTP-binding proteins. This is being used to detect the activation of GTPase (mainly of the Rab family) that are relevant to insulin action in insulin responsive tissues such as adipose, heart and skeletal muscle</gtr:description><gtr:id>F0035242-BACF-4750-9D43-6D747D245935</gtr:id><gtr:impact>Patent</gtr:impact><gtr:outcomeId>rzZnuHSBghJ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Photolabel for GTP binding proteins</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>C13 isotope tags on GTP photolabel. For use inproteomic analysis of GTP binding proteins</gtr:description><gtr:id>967A336F-9147-44B0-8C33-DBCA262EB4B7</gtr:id><gtr:impact>Unpublished data</gtr:impact><gtr:outcomeId>pgrfVYKqUpz</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Isotope tags on GTP photolabels</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a photoaffinity labelling reagent which can be used to study glucose transporters at the surface of cells. We have used it to determine the extent to which the glucose transporter GLUT4 is translocated in response to insulin and how this process is impaired in type 2 diabetes</gtr:description><gtr:id>EB895C8B-F73D-4E86-88B7-54DD98F2C075</gtr:id><gtr:impact>Used with clinical samples including muscle from type 2 diabetes patients. This was a collaborative study with a group at the Karolinska Institute, Stockholm, Sweden</gtr:impact><gtr:outcomeId>6D52E0BE5C3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Photochemical reagent for analysis of GLUT4 translocation</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2BB8FC72-70EF-4474-8A40-BF8A0691C0B4</gtr:id><gtr:title>A common trafficking route for GLUT4 in cardiomyocytes in response to insulin, contraction and energy-status signalling.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a65ae60ba39b87929425faaf7cd982"><gtr:id>53a65ae60ba39b87929425faaf7cd982</gtr:id><gtr:otherNames>Fazakerley DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>668AFD4E986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01A28A4F-CFBB-4F5B-ADE5-6730D28F6821</gtr:id><gtr:title>Developmental programming mediated by complementary roles of imprinted Grb10 in mother and pup.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5c733365c4db4772c714fc0f961435"><gtr:id>ec5c733365c4db4772c714fc0f961435</gtr:id><gtr:otherNames>Cowley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>doi_55f944944a1bfd32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F42C6B7A-8B07-4A4A-91DD-1AB9315501E9</gtr:id><gtr:title>Physiological and molecular responses to an acute bout of reduced-exertion high-intensity interval training (REHIT).</gtr:title><gtr:parentPublicationTitle>European journal of applied physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24734a5f63c91c27db0be5013b8e15c2"><gtr:id>24734a5f63c91c27db0be5013b8e15c2</gtr:id><gtr:otherNames>Metcalfe RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1439-6319</gtr:issn><gtr:outcomeId>58c6b460d67086.22639443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C8CFCC6-BB43-4F9A-9042-150B20EFBF80</gtr:id><gtr:title>GLUT4 traffic through an ESCRT-III-dependent sorting compartment in adipocytes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14275_25_23049745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BCD6E36-80F3-4554-AEF3-ACE3A1CE252F</gtr:id><gtr:title>Deletion of both Rab-GTPase-activating proteins TBC14KO and TBC1D4 in mice eliminates insulin- and AICAR-stimulated glucose transport. Diabetes 2015;64:746-759.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ba2f0c2bdaf979e5a97dad528d7aea0"><gtr:id>3ba2f0c2bdaf979e5a97dad528d7aea0</gtr:id><gtr:otherNames>Chadt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>58c6b460a2dbf6.05224182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CD40262-BE0A-426A-A54A-E3867ABC2A82</gtr:id><gtr:title>Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c4df4241d0e1193d5aeffe9e19aab3d"><gtr:id>1c4df4241d0e1193d5aeffe9e19aab3d</gtr:id><gtr:otherNames>Yang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>848C6C99184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7D16F1E-77BA-4FEC-B167-0E9305D5323F</gtr:id><gtr:title>Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a65ae60ba39b87929425faaf7cd982"><gtr:id>53a65ae60ba39b87929425faaf7cd982</gtr:id><gtr:otherNames>Fazakerley DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>7A8D8903100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB6ED7B0-3AD8-43ED-A8DE-1E503A881E59</gtr:id><gtr:title>Highly Potent and Isoform Selective Dual Site Binding Tankyrase/Wnt Signaling Inhibitors That Increase Cellular Glucose Uptake and Have Antiproliferative Activity.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/091d02cfdda8e008b3519583ad186a2c"><gtr:id>091d02cfdda8e008b3519583ad186a2c</gtr:id><gtr:otherNames>Nathubhai A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>58c6b45fd84679.44381481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFBADB7E-FFCA-4D78-8168-7E60BF5F4749</gtr:id><gtr:title>Regulating the motor for GLUT4 vesicle traffic.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26706a910ee9fec6f94954eecde88210"><gtr:id>26706a910ee9fec6f94954eecde88210</gtr:id><gtr:otherNames>Holman GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>B53279DCACD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>817BEE2B-9F5B-48F0-B934-A6036EDFED05</gtr:id><gtr:title>Insulin signaling meets vesicle traffic of GLUT4 at a plasma-membrane-activated fusion step.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>pm_14275_15_16154100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14E8953C-B998-44FA-9A9D-F14FED35A0D6</gtr:id><gtr:title>Translocation of the Na+/H+ exchanger 1 (NHE1) in cardiomyocyte responses to insulin and energy-status signalling.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccb286129508058a760f81ea6c52eea1"><gtr:id>ccb286129508058a760f81ea6c52eea1</gtr:id><gtr:otherNames>Lawrence SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>E1D187BE_0E1D187BE_0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6748DBC7-2F86-4575-AA33-2046F07D12D5</gtr:id><gtr:title>Insulin and contraction stimulate exocytosis, but increased AMP-activated protein kinase activity resulting from oxidative metabolism stress slows endocytosis of GLUT4 in cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c4df4241d0e1193d5aeffe9e19aab3d"><gtr:id>1c4df4241d0e1193d5aeffe9e19aab3d</gtr:id><gtr:otherNames>Yang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14275_15_15557332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C55BA4AE-433C-41E1-87D5-AA06677A40AB</gtr:id><gtr:title>Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b82cf28b98a880d0dd4505fac4534f"><gtr:id>d3b82cf28b98a880d0dd4505fac4534f</gtr:id><gtr:otherNames>Sakamoto K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>4A3BB82DCE9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AF8D898-0764-40A2-8202-BB4CCF8C5B3A</gtr:id><gtr:title>Proteomic Analysis of GLUT4 Storage Vesicles Reveals Tumor Suppressor Candidate 5 (TUSC5) as a Novel Regulator of Insulin Action in Adipocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53a65ae60ba39b87929425faaf7cd982"><gtr:id>53a65ae60ba39b87929425faaf7cd982</gtr:id><gtr:otherNames>Fazakerley DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58c6b460790cf0.16733131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>053367D5-49E6-40E7-9C40-579DE901BD37</gtr:id><gtr:title>Thrifty Tbc1d1 and Tbc1d4 proteins link signalling and membrane trafficking pathways.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>53C14A76474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B022B61C-18FC-442C-8E56-F9173F3CE4CA</gtr:id><gtr:title>&amp;quot;Deletion of both Rab-GTPase-activating proteins TBC1D1 and TBC1D4 in mice eliminates insulin- and AICAR-stimulated glucose transport [corrected].</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ba2f0c2bdaf979e5a97dad528d7aea0"><gtr:id>3ba2f0c2bdaf979e5a97dad528d7aea0</gtr:id><gtr:otherNames>Chadt A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>546214ea7cc2c1.06571495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCB67BD5-490F-457F-9E9A-9BCB4E4367EC</gtr:id><gtr:title>Rab28 is a TBC1D1/TBC1D4 substrate involved in GLUT4 trafficking.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bf1ecd4c4c7b837a4d6237fe9fed466"><gtr:id>2bf1ecd4c4c7b837a4d6237fe9fed466</gtr:id><gtr:otherNames>Zhou Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>58c6b460489a54.05785255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5DC3381-72A3-4EA7-A9CB-BEC11BAA39C5</gtr:id><gtr:title>Insulin regulates Rab3-Noc2 complex dissociation to promote GLUT4 translocation in rat adipocytes.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>5675e5702c430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4155DF3-E796-4620-B606-7E4BE75475C9</gtr:id><gtr:title>AS160 phosphotyrosine-binding domain constructs inhibit insulin-stimulated GLUT4 vesicle fusion with the plasma membrane.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/877da3405d091ed9b0f37773fa2e381a"><gtr:id>877da3405d091ed9b0f37773fa2e381a</gtr:id><gtr:otherNames>Koumanov F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>aCFpS8Jd9KK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61F5F99B-75C2-4852-8814-9D3C71B24E54</gtr:id><gtr:title>Endofacial competitive inhibition of glucose transporter-4 intrinsic activity by the mitogen-activated protein kinase inhibitor SB203580.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c95c41618ce2af00eb9a82e0371429e"><gtr:id>0c95c41618ce2af00eb9a82e0371429e</gtr:id><gtr:otherNames>Rib? D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_14275_15_15661859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3430B4C-E4B2-44DE-8A04-9C2F7840ADFF</gtr:id><gtr:title>Kinetics of GLUT4 trafficking in rat and human skeletal muscle.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9676fb6b36c74200b87479a035f49251"><gtr:id>9676fb6b36c74200b87479a035f49251</gtr:id><gtr:otherNames>Karlsson HK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>609163E9FCC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10E9C453-7012-4C0C-9D46-982B47CD3006</gtr:id><gtr:title>The causal role of breakfast in energy balance and health: a randomized controlled trial in lean adults.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d695ac1431dd75c370be60a9980cb1e5"><gtr:id>d695ac1431dd75c370be60a9980cb1e5</gtr:id><gtr:otherNames>Betts JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn><gtr:outcomeId>5462184f39a3f5.32413407</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D840E1A-844F-4C63-8205-FD5B9979A440</gtr:id><gtr:title>Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heart.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6e95a5abb4dadf074fb1d8ba8568ab3"><gtr:id>b6e95a5abb4dadf074fb1d8ba8568ab3</gtr:id><gtr:otherNames>Miller EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>652EFDE7927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>137C63D0-75AF-4FE5-8628-D585D9F4A0DB</gtr:id><gtr:title>A novel transgenic line using the Cre-lox system to allow permanent lineage-labeling of the zebrafish neural crest.</gtr:title><gtr:parentPublicationTitle>Genesis (New York, N.Y. : 2000)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c46dc1e84933ab76a7f41f90315553e"><gtr:id>7c46dc1e84933ab76a7f41f90315553e</gtr:id><gtr:otherNames>Rodrigues FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1526-954X</gtr:issn><gtr:outcomeId>pm_15560_20_22522888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>107F089C-22BD-44F2-8D1B-EF3963099246</gtr:id><gtr:title>FGT-1 is the major glucose transporter in C. elegans and is central to aging pathways.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89e37983f3278f9c30f6594c27c0aa4a"><gtr:id>89e37983f3278f9c30f6594c27c0aa4a</gtr:id><gtr:otherNames>Feng Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_14275_25_24024580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5639B9C-33EB-4634-AED6-217CAEC01870</gtr:id><gtr:title>The causal role of breakfast in energy balance and health: a randomized controlled trial in obese adults.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0a51170617cc19edd56b1011ec24879"><gtr:id>b0a51170617cc19edd56b1011ec24879</gtr:id><gtr:otherNames>Chowdhury EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn><gtr:outcomeId>58c6b4601ce2a7.75576459</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J003417/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>